Azobenzenes
Medchemexpress LLC 4-hydroxytolbutamide | 5719-85-7 | MFCD00144466 | 99.7% | 286.35 g/mol | C12H18N2O4S | 10 MG
4-Hydroxytolbutamide is a research-grade metabolite of the antidiabetic tolbutamide, provided as a solid powder for biochemical and pharmacological studies. It is commonly used as an analytical reference standard and in in vitro metabolism experiments involving CYP2C8 and CYP2C9.
- High purity (99.7%).
- CAS number 5719-85-7 for unambiguous identification.
- Molecular weight 286.35 g/mol, suitable for analytical calculations.
- Solid powder stable when stored at -20°C for long-term storage.
- Available in small pack sizes for analytical and research use.
![Medchemexpress LLC 4-N,6-N-bis[(4-fluoro-3-methylphenyl)methyl]pyrimidine-4,6-dicarboxamide | 544678-85-5 | MFCD09878513 | 99.2% | 410.42 g/mol | C22H20F2N4O2 | 1MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000238385.png-250.jpg)
Medchemexpress LLC 4-N,6-N-bis[(4-fluoro-3-methylphenyl)methyl]pyrimidine-4,6-dicarboxamide | 544678-85-5 | MFCD09878513 | 99.2% | 410.42 g/mol | C22H20F2N4O2 | 1MG
DB04760 is a potent, highly selective, non-zinc-chelating inhibitor of matrix metalloproteinase-13 (MMP-13) with a reported biochemical IC50 of 8 nM. Preclinical studies show the compound reduces paclitaxel-induced neurotoxicity and exhibits anticancer activity. The material is supplied as a light yellow to yellow solid with high purity and recommended storage conditions for powder and solution forms.
Medchemexpress LLC FzM1.8 | 322.3 g/mol | C18H14N2O4 | 10MG
FzM1 8 derives from FzM1 is an allosteric agonist of FZD4 with pEC50 of 6 4 FzM1 8 binds to FZD4 and activates the WNT/ -catenin pathway by promoting TCF/LEF transcriptional activity in the absence of any WNT ligand FzM1 8 stabilizes FZD4 with an increased affinity for heterotrimeric G protein and stimulates the release of the G subunit that in turn activates PI3K[1]
Medchemexpress LLC Cdc7-IN-5 | 1402057-86-6 | 96.7% | 445.47 g/mol | C25H23N3O5 | 5 MG
Cdc7-IN-5 is a small-molecule inhibitor of the Cdc7 serine-threonine kinase supplied for research use. The compound is characterized by molecular formula C25H23N3O5, molecular weight 445.47 g/mol, and reported purity of about 96.7%. It is provided as a solid powder with documented solubility in DMSO and recommended storage conditions for powder and solutions.
- Potent inhibitor of Cdc7 kinase for cell cycle and DNA replication studies.
- Molecular formula C25H23N3O5; molecular weight 445.47 g/mol.
- High purity (about 96.7%).
- Soluble in DMSO; warming and sonication recommended to aid dissolution.
- Powder and solution storage conditions specified for long-term stability.
- Includes datasheet, SDS, COA, and analytical data for quality verification.
eMolecules 104691-86-3 | Medchem Express | Lupiwighteone | 5mg | 705861611 | HY-N3354 | MFCD06796683 | 338.359 | C20H18O5
Ambeed | 5-(Bromomethyl)-2-(trifluoromethyl)pyridine | 250mg | 602852497 | A793147 | 108274-33-5 | MFCD10697684 | 240.023 | C7H5BrF3N
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules 83846-85-9 | Phenyl(4-(p-tolylthio)phenyl)methanone | Ambeed | MFCD00055651 | 304.410 | C20H16OS | 98.000 | Cc1ccc(Sc2ccc(cc2)C(=O)c2ccccc2)cc1 | 5g | 600847986
Phenyl(4-(p-tolylthio)phenyl)methanone | Ambeed | 83846-85-9 | MFCD00055651 | 304.410 | C20H16OS | 98.000 | Cc1ccc(Sc2ccc(cc2)C(=O)c2ccccc2)cc1 | 5g | 600847986
Medchemexpress LLC Mind4-19 | 129544-85-0 | 99.93% | 373.47 | 50 MG
MIND4-19 is a potent SIRT2 inhibitor with an IC50 value of 7.0 μM. It can be used for researching Huntington's disease.
- Potent SIRT2 inhibitor.
- Exhibits an IC50 value of 7.0 μM for SIRT2.
- Applicable for research into Huntington's disease.
eMolecules 185259-85-2 | Medchem Express | GR-46611 | 5mg | 724441955 | HY-101248 | MFCD00953517 | 377.488 | C23H27N3O2
Medchem Express | PARP10|15-IN-3 | 5mg | 761041080 | HY-146502 | 2892064-88-7 | 274.320 | C15H18N2O3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC C-021 | 864289-85-0 | 100.0% | 467.65 g/mol | C27H41N5O2 | 25 MG
C-021 is a small-molecule CCR4 antagonist supplied for research use. It inhibits CCR4-mediated chemotaxis in human and mouse cells and blocks CCL22-induced GTPγS binding, making it suitable for biochemical and cellular assays.
- Target: CCR4 (GPCR), suitable for immunology and GPCR research.
- Potent CCR4 antagonist with reported IC50s of 140 nM (human chemotaxis), 39 nM (mouse chemotaxis), and 18 nM in GTPγS binding assays.
- Molecular formula C27H41N5O2 and molecular weight 467.65 g/mol.
- Reported purity 99.95% and solid appearance (off-white to light yellow).
- Recommended storage: powder -20°C (up to 3 years) or 4°C (up to 2 years); in solvent -80°C (6 months) or -20°C (1 month).
- Intended for research use only; not for human or animal therapeutic use.
eMolecules 947669-86-5 | Medchem Express | WWL113 | 5mg | 713704307 | HY-110148 | MFCD28160857 | 466.537 | C29H26N2O4
Medchem Express | WWL113 | 5mg | 713704307 | HY-110148 | 947669-86-5 | MFCD28160857 | 466.537 | C29H26N2O4
Medchemexpress LLC ELN318463 | 851600-86-7 | 99.5% | C19H20BrClN2O3S | 5 MG
ELN318463 is a selective γ-secretase inhibitor that targets amyloid precursor protein (APP). It exhibits differential inhibition of presenilin (PS1)- and PS2-comprised γ-secretase, showing significantly higher selectivity for PS1. This compound behaves as a classic γ-secretase inhibitor and has been shown to reduce brain Aβ levels in models of Alzheimer's disease.
- Highly selective inhibition of PS1 γ-secretase.
- Demonstrates potent inhibition of Aβ production in cells.
- Shows reduced brain Aβ levels in animal models.
- Possesses characteristics of a classic γ-secretase inhibitor.
- Off-white to light yellow solid appearance.
- Soluble in DMSO.
- Available in various quantities.
- Stable under recommended storage conditions.
Medchemexpress LLC Iclepertin | 1421936-85-7 | MFCD34474019 | 100.0% | C20H18F6N2O5S | 10MG
Iclepertin is a potent, selective, orally active glycine transporter 1 (GlyT1) inhibitor provided for research use. The compound elevates extracellular glycine and has been investigated for cognitive impairment in neurological disorders; it is intended only for laboratory research and not for human administration.
- Potent, selective glycine transporter 1 (GlyT1) inhibitor.
- Orally active; relevant for in vivo and in vitro studies.
- High chemical purity (99.97%).
- Used in preclinical research on cognitive impairment and schizophrenia.
- Available in small lab-scale pack sizes suitable for experimental workflows.
![eMolecules 13504-85-3 | Cbz-Hyp-OH | Ambeed265.265 | C13H15NO5 | 95.000 | O[C@@H]1C[C@H](N(C1)C(=O)OCc1ccccc1)C(O)=O | 25g | 490492901](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502431404.PNG-250.jpg)
eMolecules 13504-85-3 | Cbz-Hyp-OH | Ambeed265.265 | C13H15NO5 | 95.000 | O[C@@H]1C[C@H](N(C1)C(=O)OCc1ccccc1)C(O)=O | 25g | 490492901
Cbz-Hyp-OH | Ambeed | 13504-85-3265.265 | C13H15NO5 | 95.000 | O[C@@H]1C[C@H](N(C1)C(=O)OCc1ccccc1)C(O)=O | 25g | 490492901
Medchemexpress LLC Regaloside C | 117591-85-2 | 5 MG
Regaloside C is an anti-inflammatory agent and antioxidant that scavenges ABTS and DPPH free radicals. It targets multiple molecules including TNF-α, MMP-2, ERα, AKT1, TLR4, and HSP90-α, making it applicable to research related to inflammatory diseases.
- Acts as an anti-inflammatory agent.
- Acts as an antioxidant.
- Scavenges ABTS free radicals.
- Scavenges DPPH free radicals.
- Targets multiple molecules.
- Applicable to research related to inflammatory diseases.
Medchemexpress LLC Chromeceptin 5mg | 331859-86-0 | 359.35 g·mol⁻1 | C19H16F3N3O | 5 MG
Chromeceptin is a small-molecule research inhibitor of the IGF signaling pathway that suppresses IGF2 expression and reduces phosphorylation of AKT and mTOR in hepatocyte and hepatocellular carcinoma cells. Supplied for preclinical laboratory use.
- IGF signaling pathway inhibitor.
- Suppresses IGF2 expression at mRNA and protein levels.
- Reduces phosphorylation of AKT and mTOR.
- High chemical purity suitable for preclinical research.
- Available in milligram pack sizes and DMSO solution formats for convenient dosing.